Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Ruling on Massachusetts Ban on Painkiller Pending

By Pharmaceutical Processing | April 15, 2014

BOSTON (AP) — Massachusetts’ ban of a powerful new painkiller, Zohydro, remains in effect for now.

U.S. District Court Judge Rya Zobel heard more arguments Monday in a lawsuit that claims the state is overstepping its authority in restricting drug use within Massachusetts in violation of the U.S. Constitution.

The judge declined to immediately rule on a request for a temporary stay of the ban. She did not say when she would make a decision.

The ban, issued in March, is believed to be the first attempt by a state to block a federally-approved drug, according to the National Alliance for Model State Drug Laws. Zohydro is a narcotic, especially helpful in treating pain in patients who can’t take acetaminophen.

San Diego-based drugmaker Zogenix asked for the temporary stay while the company seeks an order to lift the ban permanently.

Gov. Deval Patrick has declared a public health emergency in light of widespread prescription drug abuse in the state, but has said he would lift the ban on Zohydro if the drugmaker would develop a more abuse-resistant form.

The state argues that Zohydro will “exacerbate a severe public health crisis” because the drug can be easily crushed, then snorted or injected to create an immediate and potentially lethal high.

Zogenix argued Monday that the medication has already been approved by the U.S. Food and Drug Administration. Stephen Hollman, an attorney for Zogenix, suggested that giving statewide latitude to regulate prescription drugs would erode federal authority.

“Congress intended FDA approvals to have nationwide effect,” Hollman said. “Imagine 50 states each imposing a different formulation requirement … That’s the too-many-cooks situation.”

He argued that the U.S. Supreme Court has ruled that the FDA establishes a national “floor” for drug regulation. States can impose additional safety restrictions, such as better warning labels, but cannot “eviscerate the floor established by FDA approval.”

Assistant State Attorney General Jo Ann Shotwell Kaplan countered that the Massachusetts ban does not affect the federal approval process or the company’s ability to sell the drug elsewhere in the United States. She said the ban simply represents “another hurdle” the company must surpass in order to market the drug in Massachusetts.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE